awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36852225-312484AB-E010-4D53-96ED-0B20DB01A4A3
Q36852225-312484AB-E010-4D53-96ED-0B20DB01A4A3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36852225-312484AB-E010-4D53-96ED-0B20DB01A4A3
Challenges in multiple myeloma diagnosis and treatment.
P2860
Q36852225-312484AB-E010-4D53-96ED-0B20DB01A4A3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36852225-312484AB-E010-4D53-96ED-0B20DB01A4A3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
260cf2b56c1b9f5f3f0c2f07e3cd047a3ccad2dc
P2860
BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma.